drugset / Trial / NCT03391830
Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy
RandomizedParallel-groupDouble-blindPrevention
Summary
To evaluate the benefit for statin use in prevention of of CI-AKI after computed tomography urogram (CTU).
Timeline
- Start
- 2018-01-15
- Primary completion
- 2020-01-01
- Completion
- 2020-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 40 mg | — |
| Comparator | Vitamin C | Other / unclassified | 500 mg | — |